Last update :
29/10/2024
Anticancer drug   Trastuzumab deruxtecan  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Enhertu Austria, Belgium, Bulgaria, Croatia, Denmark, France, Germany, Greece, Hungary, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Spain
References   injection   References : Trastuzumab deruxtecan  
Type Publication
4717 Manufacturer Enhertu®- Résumé des caractéristiques du produit
2022 Daiichi Sankyo Europe Gmb

  Mentions Légales